EUVIMEDEUVIMED entdecken
Crossref

Cyclin D1 expression in ductal carcinoma breast and its correlation with other prognostic markers

B. Madhumitha, B. Archana, S. Rajendiran, Kolanuvuda Sai Suhitha, Vaatsalya Balaji, Aishwarya Mohan

Sri Ramachandra Journal of Health Sciences · 27.04.2026 · 6 · 21-25

DOI: 10.25259/srjhs_8_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sri Ramachandra Journal of Health Sciences, online erschienen am 27.04.2026. Verfasst von B. Madhumitha und 5 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

In the past few decades, alarmingly, there has been a substantial increase in the incidence of breast cancer in India. Triple-negative tumors are among the various molecular types that are associated with a dismal prognosis. Expression of Cyclin D1 in tumors has been associated with tumorigenesis, suggesting its potential role as a prognostic marker of clinical significance. The study aims to evaluate cyclin D1 expression in invasive mammary cancer and its relationship to various clinicopathological and histologic parameters. Material and Methods: This is a retrospective observational study conducted on 110 cases of breast cancer specimens received in the department of pathology over 4 years. Clinicopathological data were collected. Immunohistochemistry (IHC) for Cyclin D1 was performed and statistically analyzed with other histopathological parameters.

Results

One hundred and ten cases were studied. The mean age was 54.56 ± 9.85 years. The most common molecular subtype was Luminal B (44.2%), followed by triple-negative breast cancer (TNBC) (31%) and Luminal A (21.2%). The HER2neu subtype was observed in 3.6% of cases. TNBC cases exhibited significantly higher Ki-67% expression compared to non-TNBC cases. Cyclin D1 expression was observed in 53% of breast cancers and absent in 46% of the cases; however, no significant correlation was observed between expression of Cyclin D1, tumor grade, stage, and molecular subtypes.

Conclusion

No significant correlation was observed between Cyclin D1 expression by immunohistochemistry and other prognostic markers. Further large-scale molecular studies are necessary to evaluate the potential of Cyclin D1 as a target, particularly in TNBC, which is linked to a poor prognosis.

Zitieren

APA

Madhumitha, B., Archana, B., Rajendiran, S., Suhitha, K. S., Balaji, V., & Mohan, A. (2026). Cyclin D1 expression in ductal carcinoma breast and its correlation with other prognostic markers. Sri Ramachandra Journal of Health Sciences, 6, 21-25. https://doi.org/10.25259/srjhs_8_2025

Vancouver

Madhumitha B, Archana B, Rajendiran S, Suhitha KS, Balaji V, Mohan A. Cyclin D1 expression in ductal carcinoma breast and its correlation with other prognostic markers. Sri Ramachandra Journal of Health Sciences. 2026;6:21-25. doi:10.25259/srjhs_8_2025

BibTeX
@article{Madhumitha2026,
  author = {Madhumitha, B. and Archana, B. and Rajendiran, S. and Suhitha, Kolanuvuda Sai and Balaji, Vaatsalya and Mohan, Aishwarya},
  title = {Cyclin D1 expression in ductal carcinoma breast and its correlation with other prognostic markers},
  journal = {Sri Ramachandra Journal of Health Sciences},
  year = {2026},
  volume = {6},
  pages = {21--25},
  doi = {10.25259/srjhs_8_2025}
}
Kostenlos starten →